| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5536743 | BAUSCH | Intravaginal treatment of vaginal infections with buffered metronidazole compositions |
Jul, 2013
(10 years ago) | |
Metrogel-Vaginal is owned by Bausch.
Metrogel-Vaginal contains Metronidazole.
Metrogel-Vaginal has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Metrogel-Vaginal are:
- US5536743
Metrogel-Vaginal was authorised for market use on 17 August, 1992.
Metrogel-Vaginal is available in gel;vaginal dosage forms.
Metrogel-Vaginal can be used as method of treating bacterial vaginosis.
The generics of Metrogel-Vaginal are possible to be released after 16 July, 2013.
Drugs and Companies using METRONIDAZOLE ingredient
Market Authorisation Date: 17 August, 1992
Treatment: Method of treating bacterial vaginosis
Dosage: GEL;VAGINAL
How can I launch a generic of METROGEL-VAGINAL before it's drug patent expiration?
More Information on Dosage
METROGEL-VAGINAL family patents
